{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:06:04Z","timestamp":1792951564839,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1758-5996-6-23","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T14:03:44Z","timestamp":1392732224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Genetic variation at the CYP2C19 gene associated with metabolic syndrome susceptibility in a South Portuguese population: results from the pilot study of the European Health Examination Survey in Portugal"],"prefix":"10.1186","volume":"6","author":[{"given":"V\u00e2nia","family":"Gaio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Horta Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Beleza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda","family":"Bourbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Matias","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Barreto da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"issue":"9468","key":"295_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2005, 365 (9468): 1415-1428. 10.1016\/S0140-6736(05)66378-7.","journal-title":"Lancet"},{"issue":"7","key":"295_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/er.2008-0024","volume":"29","author":"M-A Cornier","year":"2008","unstructured":"Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH: The Metabolic Syndrome. Endocr Rev. 2008, 29 (7): 777-822. 10.1210\/er.2008-0024.","journal-title":"Endocr Rev"},{"issue":"12","key":"295_CR3","first-page":"1495","volume":"27","author":"M Fiuza","year":"2008","unstructured":"Fiuza M, Cortez-Dias N, Martins S: S\u00edndrome metab\u00f3lica em Portugal: preval\u00eancia e implica\u00e7\u00f5es no risco cardiovascular-Resultados do Estudo VALSIM. Rev Port Cardiol. 2008, 27 (12): 1495-1529.","journal-title":"Rev Port Cardiol"},{"key":"295_CR4","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"K Alberti","year":"2009","unstructured":"Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K, Fruchart J, James W, Loria C, Smith S: Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circ. 2009, 120: 1640-1645. 10.1161\/CIRCULATIONAHA.109.192644.","journal-title":"Circ"},{"issue":"3","key":"295_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/sj.ejcn.1602944","volume":"63","author":"K Wijndaele","year":"2007","unstructured":"Wijndaele K, Duvigneaud N, Matton L, Duquet W, Delecluse C, Thomis M, Beunen G, Lefevre J, Philippaerts RM: Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults. Eur J Clin Nutr. 2007, 63 (3): 421-429.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"295_CR6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/sj.ijo.0803481","volume":"31","author":"A Bosy-Westphal","year":"2006","unstructured":"Bosy-Westphal A, Onur S, Geisler C, Wolf A, Korth O, Pfeuffer M, Schrezenmeir J, Krawczak M, Muller MJ: Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study. Int J Obes. 2006, 31 (5): 784-790.","journal-title":"Int J Obes"},{"issue":"11","key":"295_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/j.1467-789X.2011.00907.x","volume":"12","author":"CM Povel","year":"2011","unstructured":"Povel CM, Boer JMA, Reiling E, Feskens EJM: Genetic variants and the metabolic syndrome: a systematic review. Obes Rev. 2011, 12 (11): 952-967. 10.1111\/j.1467-789X.2011.00907.x.","journal-title":"Obes Rev"},{"issue":"4","key":"295_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrg2554","volume":"10","author":"KA Frazer","year":"2009","unstructured":"Frazer KA, Murray SS, Schork NJ, Topol EJ: Human genetic variation and its contribution to complex traits. Nat Rev Genet. 2009, 10 (4): 241-251.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"295_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2337\/db10-1011","volume":"60","author":"AT Kraja","year":"2011","unstructured":"Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, Sovio U, Mathias RA, Sun YV, Franceschini N: A Bivariate Genome-Wide Approach to Metabolic Syndrome: STAMPEED Consortium. Diabetes. 2011, 60 (4): 1329-1339. 10.2337\/db10-1011.","journal-title":"Diabetes"},{"key":"295_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ygeno.2008.07.011","volume":"92","author":"A Torkamani","year":"2008","unstructured":"Torkamani A, Topol EJ, Schork NJ: Pathway analysis of seven common diseases assessed by genome-wide association. Genomics. 2008, 92: 265-272. 10.1016\/j.ygeno.2008.07.011.","journal-title":"Genomics"},{"key":"295_CR11","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.2337\/dc06-1341","volume":"29","author":"K Wijndaele","year":"2006","unstructured":"Wijndaele K, Beunen G, Duvigneaud N, Matton L, Duquet W, Thomis M, Lefevre J, Philippaerts R: A continuous metabolic syndrome risk score: utility for epidemiological analyses. Diabetes Care. 2006, 29: 2329-","journal-title":"Diabetes Care"},{"issue":"1","key":"295_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/0778-7367-70-20","volume":"70","author":"K Kuulasmaa","year":"2012","unstructured":"Kuulasmaa K, Tolonen H, Koponen P, Kilpel\u00e4inen K, Avdicov\u00e1 M, Broda G, Calleja N, Dias C, G\u00f6sswald A, Kubinova R, et al: An overview of the European Health Examination Survey Pilot Joint Action. Arch Public Health. 2012, 70 (1): 20-10.1186\/0778-7367-70-20.","journal-title":"Arch Public Health"},{"key":"295_CR13","volume-title":"Inqu\u00e9rito de Sa\u00fade com Exame F\u00edsico: Relat\u00f3rio do estudo realizado em S\u00e3o Br\u00e1s de Alportel","author":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge","year":"2012","unstructured":"Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge: Inqu\u00e9rito de Sa\u00fade com Exame F\u00edsico: Relat\u00f3rio do estudo realizado em S\u00e3o Br\u00e1s de Alportel. 2012, Lisboa: INSA. Departamento de Epidemiologia. Departamento da Promo\u00e7\u00e3o de Sa\u00fade e Doen\u00e7as Cr\u00f3nicas,http:\/\/hdl.handle.net\/10400.18\/981,"},{"key":"295_CR14","unstructured":"FEHES - Feasibility of a European Health Examination Survey.http:\/\/www.thl.fi\/fehes\/index.html,"},{"issue":"19","key":"295_CR15","doi-asserted-by":"publisher","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","volume":"19","author":"DK Lahiri","year":"1991","unstructured":"Lahiri DK, Numberger JI: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research. 1991, 19 (19): 5444-10.1093\/nar\/19.19.5444.","journal-title":"Nucleic Acids Research"},{"key":"295_CR16","volume-title":"HardyWeinberg: Graphical tests for Hardy-Weinberg equilibrium. R package version 1.4.1","author":"J Graffelman","year":"2012","unstructured":"Graffelman J: HardyWeinberg: Graphical tests for Hardy-Weinberg equilibrium. R package version 1.4.1. 2012,http:\/\/CRAN.R-project.org\/package=HardyWeinberg,"},{"key":"295_CR17","volume-title":"Observa\u00e7\u00f5es_Boletim epidemiol\u00f3gico. Vol.1, N\u00b01, Jul-set","author":"C Matias Dias","year":"2012","unstructured":"Matias Dias C, Briz T: Distribui\u00e7\u00e3o conjunta de determinantes de sa\u00fade relacionados com comportamentos na popula\u00e7\u00e3o portuguesa. Observa\u00e7\u00f5es_Boletim epidemiol\u00f3gico. Vol.1, N\u00b01, Jul-set. 2012, Lisboa: Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge,http:\/\/hdl.handle.net\/10400.18\/878,"},{"key":"295_CR18","unstructured":"National Center for Biotechnology Information.http:\/\/www.ncbi.nlm.nih.gov\/,"},{"key":"295_CR19","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1371\/currents.RRN1208","volume":"3","author":"R Mihaescu","year":"2011","unstructured":"Mihaescu R, Meigs J, Sijbrands E, Janssens AC: Genetic risk profiling for prediction of type 2 diabetes. PLoS Curr. 2011, 3: 1208-","journal-title":"PLoS Curr"},{"issue":"2","key":"295_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/ng.520","volume":"42","author":"J Dupuis","year":"2010","unstructured":"Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, Wheeler E, Glazer NL, Bouatia-Naji N, Gloyn AL: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010, 42 (2): 105-116. 10.1038\/ng.520.","journal-title":"Nat Genet"},{"issue":"3","key":"295_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1525-1578(10)60624-1","volume":"2","author":"D Crisan","year":"2000","unstructured":"Crisan D, Carr J: Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn. 2000, 2 (3): 105-115. 10.1016\/S1525-1578(10)60624-1.","journal-title":"J Mol Diagn"},{"issue":"2","key":"295_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/hmg\/ddn341","volume":"18","author":"M Eijgelsheim","year":"2009","unstructured":"Eijgelsheim M, Aarnoudse ALHJ, Rivadeneira F, Kors JA, Witteman JCM, Hofman A, van Duijn CM, Uitterlinden AG, Stricker BHC: Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration. Hum Mol Genet. 2009, 18 (2): 347-357.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"295_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1086\/339621","volume":"70","author":"K Ranade","year":"2002","unstructured":"Ranade K, Jorgenson E, Sheu WHH, Pei D, Hsiung CA, Chiang F-T, Chen Y-DI, Pratt R, Olshen RA, Curb D, et al: A Polymorphism in the \u03b21 Adrenergic Receptor Is Associated with Resting Heart Rate. Am J Hum Genet. 2002, 70 (4): 935-942. 10.1086\/339621.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"295_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12263-010-0193-7","volume":"6","author":"R Dias","year":"2011","unstructured":"Dias R, Gowdak M, Pereira A: Genetics and cardiovascular system: influence of human genetic variants on vascular function. Genes Nutr. 2011, 6 (1): 55-62. 10.1007\/s12263-010-0193-7.","journal-title":"Genes Nutr"},{"key":"295_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev.nutr.25.050304.092656","volume":"25","author":"D Corella","year":"2005","unstructured":"Corella D, Ordovas JM: Single Nucleotide Polymorphisms that influence lipid metabolism. Interaction with Dietary Factors. Annu Rev of Nutr. 2005, 25: 341-390. 10.1146\/annurev.nutr.25.050304.092656.","journal-title":"Annu Rev of Nutr"},{"issue":"3","key":"295_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00787-010-0096-6","volume":"19","author":"A Hinney","year":"2010","unstructured":"Hinney A, Vogel CG, Hebebrand J: From monogenic to polygenic obesity: recent advances. Eur Child Adolesc Psychiatr. 2010, 19 (3): 297-310. 10.1007\/s00787-010-0096-6.","journal-title":"Eur Child Adolesc Psychiatr"},{"issue":"6","key":"295_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1046\/j.1463-1326.2002.00227.x","volume":"4","author":"A Marti","year":"2002","unstructured":"Marti A, Corbal\u00e1n MS, Mart\u00ednez-Gonzalez MA, Martinez JA: TRP64ARG polymorphism of the \u03b23-adrenergic receptor gene and obesity risk: effect modification by a sedentary lifestyle. Diabetes Obes Metab. 2002, 4 (6): 428-430. 10.1046\/j.1463-1326.2002.00227.x.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"295_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1521-0391.2010.00069.x","volume":"19","author":"L Bauer","year":"2010","unstructured":"Bauer L, Dick D, Bierut L, Bucholz K, Edenberg H, Kuperman S, Kramer J, Nurnberger J, O\u2019Connor S, Rice J, et al: Obesity, Smoking, and Frontal Brain Dysfunction. Am J Addict. 2010, 19 (5): 391-400. 10.1111\/j.1521-0391.2010.00069.x.","journal-title":"Am J Addict"},{"issue":"1","key":"295_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.pharmthera.2011.03.011","volume":"131","author":"L Zhang","year":"2011","unstructured":"Zhang L, Bijker MS, Herzog H: The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancer. Pharmacol Ther. 2011, 131 (1): 91-113. 10.1016\/j.pharmthera.2011.03.011.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"295_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.0306-5251.2001.01499.x","volume":"52","author":"JA Goldstein","year":"2001","unstructured":"Goldstein JA: Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol. 2001, 52 (4): 349-355. 10.1046\/j.0306-5251.2001.01499.x.","journal-title":"Br J Clin Pharmacol"},{"key":"295_CR31","first-page":"217","volume":"60","author":"N Bo\u017eina","year":"2009","unstructured":"Bo\u017eina N, Bradamante V, Lovri\u0107 M: Genetic Polymorphism of Metabolic Enzymes P450 (CYP) as a Susceptibility Factor for Drug Response, Toxicity, and Cancer Risk. Arch Ind Hyg Toxicol. 2009, 60: 217-","journal-title":"Arch Ind Hyg Toxicol"},{"issue":"2","key":"295_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1469-1809.2007.00417.x","volume":"72","author":"C Bertrand-Thi\u00e9bault","year":"2008","unstructured":"Bertrand-Thi\u00e9bault C, Berrahmoune H, Thompson A, Marie B, Droesch S, Siest G, Foernzler D, Visvikis-Siest S: Genetic Polymorphism of CYP2C19 Gene in the Stanislas Cohort. A link with Inflammation. Ann Hum Genet. 2008, 72 (2): 178-183. 10.1111\/j.1469-1809.2007.00417.x.","journal-title":"Ann Hum Genet"},{"key":"295_CR33","first-page":"75","volume-title":"Clinical Applications of Pharmacogenomics","author":"S Pavlovic","year":"2012","unstructured":"Pavlovic S, Zukic B, Nikcevic G: Pharmacogenomics of Thiopurine S Methyltransferase: Clinical Applicability of Genetic Variants, Clinical Applications of Pharmacogenetics. Clinical Applications of Pharmacogenomics. Edited by: Sanoudou D. 2012, Rijeka: Tech, 75-94."},{"issue":"2","key":"295_CR34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00125817-200203000-00002","volume":"4","author":"JN Hirschhorn","year":"2002","unstructured":"Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K: A comprehensive review of genetic association studies. Genet Med. 2002, 4 (2): 45-61. 10.1097\/00125817-200203000-00002.","journal-title":"Genet Med"},{"issue":"2","key":"295_CR35","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/hrt.2011.227652","volume":"98","author":"M Zabalza","year":"2012","unstructured":"Zabalza M, Subirana I, Sala J, Lluis-Ganella C, Lucas G, Tom\u00e1s M, Masi\u00e1 R, Marrugat J, Brugada R, Elosua R: Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel. Heart. 2012, 98 (2): 100-108. 10.1136\/hrt.2011.227652.","journal-title":"Heart"},{"issue":"3","key":"295_CR36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.pharmthera.2009.12.002","volume":"125","author":"BNM Zordoky","year":"2010","unstructured":"Zordoky BNM, El-Kadi AOS: Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther. 2010, 125 (3): 446-463. 10.1016\/j.pharmthera.2009.12.002.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"295_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1517\/17425251003598878","volume":"6","author":"B Giusti","year":"2010","unstructured":"Giusti B, Gori AM, Marcucci R, Abbate R: Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis. Expert Opin Drug Metab Toxicol. 2010, 6 (4): 393-407. 10.1517\/17425251003598878.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"295_CR38","unstructured":"CYP2C19 allele nomenclature.http:\/\/www.imm.ki.se\/CYPalleles\/cyp2c19.htm,"},{"key":"295_CR39","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1365-2125.2009.03578.x","volume":"69","author":"A Li-Wan-Po","year":"2010","unstructured":"Li-Wan-Po A, Girard T, Farndon P, Cooley C, Lithgow J: Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17. Br J Clin Pharmacol. 2010, 69: 222-230. 10.1111\/j.1365-2125.2009.03578.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"295_CR40","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000346799","volume":"62","author":"J Mutschler","year":"2013","unstructured":"Mutschler J, Abbruzzese E, Wiedemann K, von der Goltz C, Dinter C, Mobascher A, Thiele H, Diaz-Lacava A, Dahmen N, Gallinat J, et al: Functional Polymorphism in the Neuropeptide Y Gene Promoter (rs16147) Is Associated with Serum Leptin Levels and Waist-Hip Ratio in Women. Ann Nutr Met. 2013, 62 (4): 271-276. 10.1159\/000346799.","journal-title":"Ann Nutr Met"},{"issue":"6","key":"295_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.2047-6310.2012.00069.x","volume":"7","author":"S Hohmann","year":"2012","unstructured":"Hohmann S, Buchmann AF, Witt SH, Rietschel M, Jennen-Steinmetz C, Schmidt MH, Esser G, Banaschewski T, Laucht M: Increasing association between a neuropeptide Y promoter polymorphism and body mass index during the course of development. Pediatr Obes. 2012, 7 (6): 453-460. 10.1111\/j.2047-6310.2012.00069.x.","journal-title":"Pediatr Obes"},{"issue":"7109","key":"295_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nature05026","volume":"443","author":"GJ Morton","year":"2006","unstructured":"Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW: Central nervous system control of food intake and body weight. Nat. 2006, 443 (7109): 289-295. 10.1038\/nature05026.","journal-title":"Nat"},{"issue":"7","key":"295_CR43","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2217\/pme.12.85","volume":"9","author":"PA Blaker","year":"2012","unstructured":"Blaker PA, Arenas-Hernandez M, Marinaki AM, Sanderson JD: The pharmacogenetic basis of individual variation in thiopurine metabolism. Pers Med. 2012, 9 (7): 707-725. 10.2217\/pme.12.85.","journal-title":"Pers Med"},{"key":"295_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1741-7015-11-197","volume":"11","author":"J Castiblanco","year":"2013","unstructured":"Castiblanco J, Arcos-Burgos M, Anaya JM: What is next after the genes for autoimmunity?. BMC Med. 2013, 11: 197-10.1186\/1741-7015-11-197.","journal-title":"BMC Med"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-5996-6-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:08:39Z","timestamp":1630552119000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/1758-5996-6-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,18]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["295"],"URL":"https:\/\/doi.org\/10.1186\/1758-5996-6-23","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,18]]},"assertion":[{"value":"4 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}